Results 151 to 160 of about 6,430 (245)

Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan [PDF]

, 2017
Artur A. Isaev, Gimat D. Dalgatov, Ivan A. Yakovlev, Mikhail O. Mavlikeev, Olga N. Chernova, Patimat G. Akhmedova, Raisat M. Magomedova, Roman V. Deev, Sergei N. Bardakov, Valerii P. Fedotov, Zoya R. Umakhanova   +10 more
core   +1 more source

Additional file 2 of Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice

Additional file 2. Fig. S2. Localisation and quantification of dysferlin protein expression in dysferlin exon 40a knockout mice generated by CRISPR/Cas-9 genome editing. (A) Immunofluorescent staining for dysferlin using NCL Hamlet-1 on quadriceps muscle sections from 12-month-old WT, dysferlin 40aKO and BLAJ mice.
Yasa, Joe, Reed, Claudia E., Bournazos, Adam M., Evesson, Frances J., Pang, Ignatius, Graham, Mark E., Wark, Jesse R., Nijagal, Brunda, Kwan, Kim H., Kwiatkowski, Thomas, Jung, Rachel, Weisleder, Noah, Cooper, Sandra T., Lemckert, Frances A.   +13 more
openaire   +1 more source

DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation. [PDF]

JCI Insight
Bruge C, Bourg N, Pellier E, Miagoux Q, Benabides M, Grossi N, Hayat H, Jarrige M, Polveche H, Agostini V, Brureau A, Vassilopoulos S, Evangelista T, Fernández-Eulate G, Stojkovic T, Richard I, Nissan X.   +16 more
europepmc   +1 more source

Dysferlinopathies: phenotypic study of a Moroccan series of 28 cases. [PDF]

Acta Myol
Mouloudi N, Kably B, Sefiani S, Birouk N.   +3 more
europepmc   +1 more source

Gene Selection for Multiclass Prediction by Weighted Fisher Criterion [PDF]

, 2007
Jianhua Xuan, Yue Wang, Yibin Dong, Yuanjian Feng, Bin Wang, Javed Khan, Maria Bakay, Zuyi Wang, Lauren Pachman, Sara Winokur, Yi-Wen Chen, Robert Clarke, Eric Hoffman   +12 more
core   +1 more source

The fungal peptide toxin candidalysin induces distinct membrane repair mechanisms compared to bacterial pore-forming toxins. [PDF]

Cell Death Discov
Thapa R, Kayejo V, Lyon CM, Hube B, Naglik JR, Keyel PA.   +5 more
europepmc   +2 more sources

Initial presentation with elevated transaminases and subsequent hematuria in limb-girdle muscular dystrophy type 2B: A case report. [PDF]

Medicine (Baltimore)
Ji Z, Zheng H, Yang Y, Li D, Li Z, Guo X.   +5 more
europepmc   +1 more source

Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trialP [PDF]

, 2018
et al,, Harms, Matthew, Pestronk, Alan
core   +1 more source

Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathy. [PDF]

Genes Dis
Bouchard C, Despax L, Rousseau J, Tremblay JP.   +3 more
europepmc   +1 more source

Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy. [PDF]

Neurol Neuroimmunol Neuroinflamm
Kang S, Wang Q, Lv H, Deng J, Zhang W, Lu X, Yuan Y, Wang Z, Zheng F, Yu M.   +9 more
europepmc   +1 more source